Analyst Price Targets — OLN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 10, 2026 12:26 pm | — | RBC Capital | $30.00 | $28.91 | TheFly | Olin price target raised to $30 from $21 at RBC Capital |
| April 9, 2026 12:21 pm | — | UBS | $29.00 | $28.40 | TheFly | Olin price target raised to $29 from $21 at UBS |
| February 17, 2026 12:05 pm | Eldain Rodriguez | Mizuho Securities | $24.00 | $25.88 | TheFly | Olin price target raised to $24 from $22 at Mizuho |
| February 10, 2026 3:37 pm | — | Deutsche Bank | $26.00 | $25.88 | TheFly | Olin price target raised to $26 from $23 at Deutsche Bank |
| February 3, 2026 12:25 pm | — | BMO Capital | $24.00 | $22.17 | TheFly | Olin price target lowered to $24 from $25 at BMO Capital |
| February 2, 2026 9:02 pm | Duffy Fischer | Goldman Sachs | $22.00 | $22.17 | StreetInsider | Goldman Sachs Reiterates Neutral Rating on Oiln (OLN) |
| February 2, 2026 3:08 pm | Peter Osterland | Truist Financial | $20.00 | $21.92 | TheFly | Olin price target lowered to $20 from $23 at Truist |
| February 2, 2026 1:48 pm | — | UBS | $21.00 | $21.19 | TheFly | Olin price target lowered to $21 from $22 at UBS |
| February 2, 2026 1:40 pm | — | RBC Capital | $21.00 | $20.96 | TheFly | Olin price target lowered to $21 from $24 at RBC Capital |
| February 2, 2026 1:32 pm | — | Morgan Stanley | $18.00 | $20.97 | TheFly | Olin price target lowered to $18 from $20 at Morgan Stanley |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for OLN

Olin is expected to implement one of its largest cost-saving goals this year, estimated to be between $100 and $120 million. Given that we are starting to see top line recovery, mainly driven by the epoxy segment, cost savings will bring margin expansion. Momentum, growth, and profitability metrics are improving well and are superior to its peers, but the valuation remains depressed with an upside potential of 68%…

Olin remains a buy as Middle East conflict tightens global petrochemical supply, supporting US-centric producers and improving pricing power. OLN's Q1 likely marks the bottom, with Q2 expected to benefit from lower US natural gas prices and improved margins, especially in Chlor Alkali. Despite weak construction demand, supply disruptions and cost tailwinds should drive at least $150M free cash flow in 2026, with…

CLAYTON, Mo., April 2, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced today that on Friday, May 8, 2026, at 9:00 a.m.

OLN324 demonstrated meaningfully faster and greater improvements in anatomic outcomes in DME and numerically greater vision gains sustained through 20 weeks with fewer retreatments as compared to faricimab New anatomic data demonstrates OLN324 achieves faster, greater, and more durable reductions in wAMD pigment epithelial detachment (PED) thickness versus faricimab Ollin and Innovent Biologics adva ncing OLN324…

SG Americas Securities LLC raised its position in Olin Corporation (NYSE: OLN) by 142.0% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 455,757 shares of the specialty chemicals company's stock after acquiring an additional 267,458 shares during the quarter.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for OLN.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
